Bone drugs may give breast cancer patients extra boost

02/12/2009 |

A study involving 1,803 premenopausal women showed participants who took the bone drug zoledronic acid had a 36% reduction in cancer recurrences and metastases, compared with women who did not take the drug. Results of two other large studies on bone drugs and breast cancer are expected in the next few years.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI